These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24729783)

  • 1. Synergistic Antiproliferative Effects of Combined γ -Tocotrienol and PPAR γ Antagonist Treatment Are Mediated through PPAR γ -Independent Mechanisms in Breast Cancer Cells.
    Malaviya A; Sylvester PW
    PPAR Res; 2014; 2014():439146. PubMed ID: 24729783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling.
    Shirode AB; Sylvester PW
    Biomed Pharmacother; 2010 May; 64(5):327-32. PubMed ID: 19954924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms Mediating the Effects of γ-Tocotrienol When Used in Combination with PPARγ Agonists or Antagonists on MCF-7 and MDA-MB-231 Breast Cancer Cells.
    Malaviya A; Sylvester PW
    Int J Breast Cancer; 2013; 2013():101705. PubMed ID: 23431460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines.
    Akl MR; Ayoub NM; Abuasal BS; Kaddoumi A; Sylvester PW
    Fitoterapia; 2013 Jan; 84():347-59. PubMed ID: 23266736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms Mediating the Synergistic Anticancer Effects of Combined γ-Tocotrienol and Celecoxib Treatment.
    Shirode AB; Sylvester PW
    J Bioanal Biomed; 2011 Jan; 3():1-7. PubMed ID: 22140606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma.
    Badawi AF; Eldeen MB; Liu Y; Ross EA; Badr MZ
    Cancer Res; 2004 Feb; 64(3):1181-9. PubMed ID: 14871855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The peroxisome proliferator-activated receptor-gamma ligand 15-deoxyDelta12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock.
    Abdelrahman M; Collin M; Thiemermann C
    Shock; 2004 Dec; 22(6):555-61. PubMed ID: 15545828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
    Patel KM; Wright KL; Whittaker P; Chakravarty P; Watson ML; Ward SG
    Cell Signal; 2005 Sep; 17(9):1098-110. PubMed ID: 15993751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
    Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
    Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats.
    Churi SB; Abdel-Aleem OS; Tumber KK; Scuderi-Porter H; Taylor BK
    J Pain; 2008 Jul; 9(7):639-49. PubMed ID: 18387855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A; Moulin D; Sebillaud S; Koufany M; Galteau MM; Netter P; Terlain B; Jouzeau JY
    Arthritis Res Ther; 2005; 7(6):R1325-37. PubMed ID: 16277686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 15-deoxy-Delta 12,14-ProstaglandinJ2 regulates dedifferentiation through peroxisome proliferator-activated receptor-gamma-dependent pathway but not COX-2 expression in articular chondrocytes.
    Lee JH; Yu SM; Yoon EK; Lee WK; Jung JC; Kim SJ
    J Korean Med Sci; 2007 Oct; 22(5):891-7. PubMed ID: 17982241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPAR-gamma-mediated regulation of normal and malignant B lineage cells.
    Padilla J; Kaur K; Harris SG; Phipps RP
    Ann N Y Acad Sci; 2000 Apr; 905():97-109. PubMed ID: 10818446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15-Deoxy-∆-
    Li J; Guo C; Wu J
    PPAR Res; 2019; 2019():7242030. PubMed ID: 31467514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.
    Li Y; Wen X; Spataro BC; Hu K; Dai C; Liu Y
    J Am Soc Nephrol; 2006 Jan; 17(1):54-65. PubMed ID: 16291834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
    Liu JJ; Liu PQ; Lin DJ; Xiao RZ; Huang M; Li XD; He Y; Huang RW
    Ann Hematol; 2007 Mar; 86(3):173-83. PubMed ID: 17089125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions.
    Bernardo A; Levi G; Minghetti L
    Eur J Neurosci; 2000 Jul; 12(7):2215-23. PubMed ID: 10947800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
    Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
    FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy.
    Tiwari RV; Parajuli P; Sylvester PW
    Mol Cell Biochem; 2015 Oct; 408(1-2):123-37. PubMed ID: 26112904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.